NUWE Stock Analysis
NU
Uncovered
Nuwellis Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 70 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex SmartFlow and the Aquadex FlexFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid (primarily excess salt and water) from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and an LCD screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filter, sensors, and connectors that contain and deliver the blood from and back to the patient; and a disposable catheter.